Teva and Jiangsu Nhwa Forge Strategic Partnership to Promote Patient Access to AUSTEDO in China - Seite 3

¹ Haddad MS, Cummings JL. Psychiatr Clin North Am 1997;20:791–807

² Hui L, et al. Schizophr Res. 2017 Apr;182:104-109.

³ Uludag K, et al. Asian J Psychiatr. 2021 Dec;66:102877.

⁴ Liang Q, et al. J Psychiatr Res. 2022 Jul;151:181-187.

⁵ Carbon M, et al. J Clin Psychiatry. 2017 Mar;78(3):e264-e278

View source version on businesswire.com: https://www.businesswire.com/news/home/20240226932316/en/

The Teva Pharmaceutical Industries Stock at the time of publication of the news with a raise of +4,60 % to 12,50EUR on Tradegate stock exchange (26. Februar 2024, 13:04 Uhr).